Company Profile
Updated: 17-SEP-09Abbott Molecular
Private Subsidiary, Headquarters Location
1300 E Touhy, Des Plaines, IL 60018-3315, United States
(800)553-7042, (224)361-7000, (630)271-7414 fax, http://www.abbottmolecular.com
Primary SIC: Noncommercial Research Organizations, Primary NAICS: Research and Development in the Physical Sciences and Engineering Sciences
Description: Services: A Genomic Disease Management company that develops, commercializes and markets clinical products providing information critical to the evaluation and management of cancer, prenatal disorders and other genetic diseases.
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
IRIS International Promotes Lawrence J. Blecka.
Investrend; 11/17/2009; 981 words; ...a distinguished career with Abbott Laboratories, Diagnostics...two years. As director of Abbott's Probe Diagnostics Venture...which is sold TODAY as the Abbott LCx. He also managed the development...biology (with an emphasis in molecular biology) from Northern Illinois...
Cardiac Science Appoints Healthcare Executive Ronald A. Andrews, Jr. to Board of Directors.
Cancer Weekly; 11/17/2009; 901 words; ...development at Pleasanton, CA-based Roche Molecular Diagnostics, where he was responsible...president, U.S. commercial operations, molecular diagnostics, and vice president, marketing...executive development programs at Roche and Abbott Labs. Keywords: Automated External...
Molecular Diagnostics Market: DNA Probes and Biochips - New Product Development Opportunities and Business Expansion Strategies for Instrument and Reagent Suppliers.
Nanotechnology Weekly; 11/16/2009; 693 words; ...opportunities presented by the molecular diagnostics market, many...opportunities emerging in the molecular diagnostics market during...SOME COMPETITIVE PROFILES Abbott Aclara Affymetrix Agilent...com/research/64550c/molecular_diagnost Keywords: Health...
Celera Corporation Reports Third Quarter 2009 Results.(Financial report)
Investment Weekly News; 11/14/2009; 902 words; ...management (Corporate). Most of the Company's molecular diagnostic business is conducted through distribution and royalty agreements with Abbott Molecular, a subsidiary of Abbott Laboratories. The Corporate segment includes...
PanGenetics Announces Acquisition by Abbott of PG110 anti-NGF Antibody to Treat Chronic Pain.
Business Wire; 11/12/2009; 1674 words; ...in Rome. About Abbott: Abbott is a global, broad-based...in more than 130 countries. Abbott's news releases and other...company's Web site at www.abbott.com About PanGenetics: PanGenetics...Therapeutics, Genmab, Micromet, Molecular Partners and NormOxys, For...
Recent News Articles
- Abbott Introduces Molecular Diagnostic System Intended for Broad Identification of Infectious Agents.
Biotech Week - August 05, 2009 - Abbott Introduces Molecular Diagnostic System Intended for Broad Identification of Infectious Agents.
PR Newswire - July 21, 2009 - Abbott and GSK to Collaborate on Molecular Diagnostic Test to Select Candidate Patients for Future Cancer Immunotherapy.
PR Newswire - July 13, 2009 - Abbott & BioGenex Extend the Technology Co-development and Distribution Agreement for Marketing the Xmatrx(R) Advanced Staining Platform for the Automation of FISH, IHC and ISH Molecular Diagnostic Assays.
Biotech Week - June 17, 2009
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning